Picture [iito] Life Science Business Portals Media Data 2022 650x100px
Organisation › Details

UCB S.A. (Euronext: UCB)

UCB, Brussels, Belgium ( is a biopharmaceutical company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing more than 9 000 people in over 40 countries, UCB produced revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB). *


Period Start 1928-01-01 established
  Group UCB (Group)
Products Industry pharmaceutical
  Industry 2 CNS drug
Region Region Brussels
  Country Belgium
  Street 60 Allée de la Recherche
  City 1070 Brussels
  Tel +32-2-559-9999
    Address record changed: 2020-12-02
Basic data Employees G: 5,001 to 10,000 (2017-12-31)
  Currency EUR
  Annual sales 4,632,000,000 (revenue, consolidated (2018) 2018-12-31)
  Profit 823,000,000 (2018-12-31)
  Cash 1,049,000,000 (2017-12-31)
    * Document for �About Section�: 
Record changed: 2022-01-21


Picture [iito] No Content Marketing 650x100px

More documents for UCB (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] [LSE] Business Portal 650x300px

» top